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Abstract
Introduction. Sucla2, a b subunit of succinyl coenzyme A synthase, is located in the mitochondrial matrix. Sucla2 
catalyzes the reversible synthesis of succinate and adenosine triphosphate (ATP) in the tricarboxylic acid cycle. 
Sucla2 expression was found to be correlated with the capacitation of boar spermatozoa. We have previously 
reported that Sucla2 was decreased in the testes of rats with spermatogenesis failure after exposure to endo-
crine disruptor BDE47. Yet, the expression model of Sucla2 in spermatogenesis and the function of Sucla2 
in spermatogenic cells are still unclear. Our objective was to explore the localization of Sucla2 during mouse 
spermatogenesis and its function in the mouse spermatocyte line (GC2). 
Material and methods. The localization of Sucla2 in the mouse testis was explored through immunohistochem-
istry (IHC). Sucla2 was knocked down in GC2 cells and its expression was detected by Western blot (WB) to 
verify the efficiency of the siRNA transfection. Mitochondrial membrane potential (MMP), apoptosis and ROS 
of GC2 were detected by flow cytometry. ATP production was measured by the luminometric method and the 
presence of Bcl2 of GC2 was detected by WB. 
Results. Sucla2 is highly expressed in all germ cells but not in interstitial cells. Coarse Sucla2 signals are found 
in spermatocytes in stages VII–XII of mouse spermatogenesis. In GC2 cells, knockdown of Sucla2 decreased 
cell viability and MMP, induced apoptosis of GC2 cells, decreased ATP production, and Bcl2 expression, and 
increased ROS levels. 
Conclusions. Sucla2 is related to the developmental stages of mouse spermatogenesis. Knockdown of Sucla2 
decreases the viability of mouse spermatocytes by inducing apoptosis via decreased mitochondrial function of 
the cells. (Folia Histochemica et Cytobiologica 2016, Vol. 54, No. 3, 134–142)
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Introduction
Sucla2, a b subunit of Succinyl coenzyme A synthase, is 
located in the mitochondria and catalyzes the reversi-
ble synthesis of succinate and adenosine triphosphate 
(ATP) in the tricarboxylic acid cycle. Sucla2 is encoded 
by the nuclear gene SUCLA2 [1], and is associated with 
the maintenance of mitochondrial DNA (mtDNA) 
and function of mitochondria [2]. Defects in the 
SUCLA2 gene result in myopathic mtDNA depletion 
syndrome, characterized by a significant reduction in 
mtDNA levels and mitochondrial dysfunction [3–5]. 
In patients with SUCLA2 mutation, impaired pro-
duction of ATP and high levels of reactive oxygen 
species (ROS) were found in fibroblasts [6]. Only 
a few authors have studied Sucla2 expression in males. 
Recently, proteomic analysis showed that Sucla2 
is related to capacitation of boar spermatozoa [7]. 
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In a previous study, we found that the protein level 
of Sucla2 was decreased in testes of rats with sper-
matogenesis failure, and decreased in mouse sper-
matogonia cell line (GC1) with increased apoptosis 
after exposure to the endocrine disruptor BDE47; 
Sucla2 is located in germ cells and is highly expressed 
in VII–XII stages of rat spermatogenesis [8]. This pre-
vious study indicates that Sucla2 is important during 
spermatogenesis, and probably plays an important 
role in the proliferation and apoptosis of germ cells. 
Nonetheless, the function of Sucla2 in mammalian 
spermatogenic cells has not yet been investigated and 
the precise localization of the Sucla2 protein in mouse 
testis is still unclear. The aim of our study was thus to 
explore the function and expression of Sucla2 during 
mouse spermatogenesis through knockdown of its 
mRNA in the mouse spermatocyte cell line (GC2).
Material and methods
Animals and treatment. Adult male ICR mice (28 ± 2 g) 
were obtained from the Laboratory Animal Center of Nan-
jing Medical University (Nanjing, China) and maintained in 
a 12/12-h light/dark cycle at 20–22°C and 50–70% humid-
ity, with food and water provided ad libitum. The animals 
were treated according to the rules of the Nanjing Medical 
University and sacrificed with carbon dioxide. Testes were 
collected and fixed in Bouin’s solution. The study was ap-
proved by The Animal Ethical Committee of Nanjing Med-
ical University, Nanjing, China; study number: 20090598). 
The fixed tissues were embedded in paraffin, sectioned, and 
stained as described before [9].
Immunohistochemistry (IHC). IHC was used to explore the 
localization of Sucla2 in mouse testes. Paraffin sections of 
mouse testes were immunostained as described previously [9]. 
In brief, deparaffinated sections of mouse testis were 
incubated in 2% H2O2 to quench the endogenous peroxi-
dase activity, washed in phosphate-buffered saline (PBS), 
blocked with a blocking serum and incubated with primary 
antibody against Sucla2 (1:50, 12627-1-AP, ProteinTech 
Group Inc., Chicago, IL, USA) overnight at 4°C. The next 
day, sections were washed with PBS, and incubated with 
HRP-conjugated secondary antibody (1:1500, ab97080, 
abcam, Cambridge, MA, USA). The immunoreactive sites 
were visualized as brown staining with diaminobenzidine and 
slides were mounted for bright-field microscopy (Axioskop 2 
plus, Zeiss, Jena, Germany).
Cell culture. GC2 cells (mouse spermatocyte line, GC2) 
were obtained from ATCC Global Bioresource Center 
(ATCC Global Bioresource Center, Atlanta, GA, USA). 
Cells were cultured in Dulbecco’s modified Eagle’s medium 
(DMED) supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin, and 25 μg/mL ascorbic acid at 37°C 
in an atmosphere containing 5% CO2 (all culture reagents 
were obtained from Sigma, St. Louis, MO, USA) [10]. 
Cell viability and counts were determined by trypan blue 
exclusion. GC2 cells were suspended in 0.04% trypan blue 
for 3 min, assuming that dead cells were stained in blue 
while viable cells were not. Cell viability was expressed as 
a percentage reflecting the number of viable cells relative 
to the number of viable cells in the control [11].
Small interference RNA (siRNA) transfection of GC2 cells. 
To explore the function of Sucla2 in germ cells, Sucla2-tar-
geting siRNA transfection was used to knock down Sucla2 
in GC2 cells. In order to explore the relationship between 
different Sucla2 levels and their effects on GC2 cells, differ-
ent volumes of Sucla2-targeting siRNA was used to knock 
down Sucla2. In brief, control siRNA (sc-37007, Santa Cruz 
Biotech, Santa Cruz, CA, USA), Sucla2 siRNA (sc-76599; 
Santa Cruz Biotech) against the mouse Sucla2 mRNA 
were diluted to a final concentration of 10 μM and stored 
at −20°C. The GC2 cells were seeded in six well culture 
plates and cultured for 24 hours until cells were 60–80% 
confluent. Cells were washed once with 2 mL transfection 
medium. For the control (Neg), added 2 mL transfection 
medium containing 12 μL transfection reagent (11668-019, 
Invitrogen Corporation, Carlsbad, CA, USA) and 12 μL 
control siRNA; in the Si1 group, added 2 mL transfection 
medium containing 12 μL transfection reagent, 6 μL control 
siRNA and 6 μL Sucla2 siRNA; in Si2 group, added 2 mL 
transfection medium containing 12 μL transfection reagent 
and 12 μL Sucla2 siRNA. Cells were cultured at 37°C for 6 h 
in a CO2 incubator. The medium was then discarded and 
2 mL of normal growth medium was added. The cells were 
incubated for additional 24 h [10]. Cells were collected for 
further analysis.
Protein extraction. After siRNA transfection, the GC2 cells 
were collected and homogenized in a lysis buffer containing 
1% (v/w) protease inhibitor cocktail (78415, Pierce Bio-
technology, Rockford, IL, USA). The mixture was shaken 
at 4°C for 1 h, and the insoluble matter was removed by 
centrifugation at 40,000 g and 4°C for 1 hour. Protein con-
centrations were determined by the Bradford method using 
BSA as the standard [8].
Western blot analysis. Protein levels of Sucla2 and Bcl2 in 
GC2 after siRNA transfection were analyzed by Western 
blot, as previously described [12]. Glyceraldehyde-3-phos-
phate dehydrogenase (Gapdh) was used as an internal 
reference. Antibodies against Sucla2 (1:1500, 12627-1-AP, 
ProteinTech Group, Inc., Chicago, IL, USA), Bcl-2 (1:50, 
sc-7382, Santa Cruz Biotech), and Gapdh (1:1000, Kc-5G5, 
KangChen Bio-tech Inc., Shanghai, China) were purchased. 
Protein samples were electrophoresed on 12% SDS poly-
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acrylamide gels and transferred to nitrocellulose membranes 
(Amersham Biosciences AB, Uppsala, Sweden). Membranes 
were then blocked in phosphate-buffered saline (PBS) 
containing 5% nonfat milk powder for 1 h, and incubated 
overnight with anti-Sucla2, anti-Bcl2, or anti-GAPDH pri-
mary antibody in PBS containing 5% nonfat milk powder. 
The next day, membranes were washed three times (10 min 
each) with PBS and incubated with horseradish peroxidase 
(HRP)-conjugated secondary antibody (Beijing ZhongShan 
Biotechnology Co. Ltd., Beijing, China) at 37°C for 1 h. Spe-
cific proteins were detected using an ECL kit (Amersham 
Biosciences, Buckinghamshire, England) and AlphaImager 
(FluorChem5500; Alpha Innotech, San Leandro, CA, USA).
Detection of mitochondrial membrane potential (MMP). 
MMP was detected by flow cytometry using JC-1 mito-
chondrial potential detection kit (C2006, Beyotime Bio-
tech, Shanghai, China) as previously indicated [8]. In brief, 
GC2 cells after Sucla2-targeting SiRNA transfection were 
incubated with JC-1 dye for 15 min in DMEM at 37°C, and 
then subjected to flow cytometry. Healthy cells emitted red 
fluorescence, while cells with disrupted MMP emitted green 
fluorescence. The red/green fluorescence ratio (Y/X ratio) is 
an indicator of MMP: a lower ratio indicates mitochondrial 
depolarization. The data were analyzed with Cell Quest 
software (Becton Dickinson, Franklin Lakes, NJ, USA).
Determination of apoptotic GC2 cells. Sucla2 siRNA trans-
fection apoptotic GC2 cells were detected by flow cytometry 
(Becton Dickinson, FACS Canto, Franklin Lakes, NJ, USA) 
using the Annexin V–FITC/PI Apoptosis Detection Kit 
(Bll-AP0103, Biouniquer Technology, Hongzhou, China). 
FITC-labeled Annexin V binds phosphatidylserine on the 
surface of apoptotic cells, but of not living cells, whereas 
PI can be excluded by living cells. The Annexin V-positive/ 
/PI-negative cells (lower right quadrant, LR) were early 
apoptotic cells, the double-positive (upper right quadrant, 
UR) were late apoptotic cells, the Annexin V-negative/ 
/PI-positive (upper left quadrant, UL) were dead/necrotic 
cells, and the double-negative cells (lower left quadrant, LL) 
were viable cells. The sum of LR and UR is the percentage 
of apoptotic GC2 cells [13].
Determination of ATP levels. GC2 cells were collected and 
washed twice, before being homogenized in lysis buffer con-
taining 1% (v/w) protease inhibitor cocktail (78415, Pierce 
Biotechnology, Rockford, IL, USA). The mixture was shaken 
at 4°C for 1 hour, and then centrifuged at 40,000 g for 1 hour at 
4°C. The supernatant was subjected to ATP measurement by 
luminometric methods, using an ATP assay kit (s0026, Beyo-
time, Shanghai, China) and a luminometer (TD-20/20, Turner 
Designs, Sunnyvale, CA, USA) as previously described [8]. 
ATP levels were also normalized to protein level to exclude 
the effect of the weight of the cell proteins.
Detection of reactive oxygen species (ROS) production. ROS 
detection kit (s0033, Beyotime Biotech, Shanghai, China) and 
flow cytometry were used to detect the reactive oxygen spe-
cies (ROS) in the cells, as described in a previous paper [14]. 
2’,7’-dichlorodihydrofluorescein diacetate (DCFH-DA, 
Sigma-Aldrich, Saint Louis, MO, USA) is a fluorescent 
dye with no fluorescence. When DCFH-DA enters into 
cytoplasm of cells, it can be oxidized by ROS to form 
2’,7’-dichlorodihydrofluorescein (DCF) emits fluorescence 
allowing ROS levels to be determined through measuring 
the DCF fluorescence intensity. The cells were collected and 
incubated with 2’,7’-dichlorodihydrofluorescein diacetate 
(DCFH-DA, Sigma-Aldrich) at 37°C for 30 min, washed 
with PBS, and analyzed by flow cytometry. 
Statistical analysis. The numerical data were generated 
from three independent experiments and expressed as 
means ± SDs. ANOVA (with the LSD post-hoc statistical 
test) was used to evaluate the significant differences between 
different groups (SSPS 20.0, IBM Co., Armonk, NY, USA). 
There results were considered to be statistically significant 
at P < 0.05. 
Results
Immunohistochemistry (IHC) of Sucla2  
in mouse testes
The IHC of Sucla2 was performed because the 
localization of Sucla2 in the mouse testis is still un-
clear. We found that Sucla2 is located specifically in 
the cytoplasm of the Sertoli cells (Ser) and all the 
spermatogenic cells such as leptotene spermatocytes 
(Lc), pachytene spermatocytes (Pc), round spermat-
ids (rSt), and elongated spermatids (eSt) (Figure 1). 
Coarse Sucla2 signals can be observed in the cyto-
plasm of Pc in stages VII–XII, but there are very faint 
signals in Leydig cells and other cells present in the 
interstitium of the testes. The expression of Sucla2 
protein in mouse testes is related to the developmen-
tal stages of spermatogenesis (Figure 1). 
Efficiency of Sucla2-targeting siRNA transfection 
and viability of GC2 cells under Sucla2 knockdown
The Western blot technique was used to verify the effi-
ciency of Sucla2-targeting siRNA transfection. Sucla2 
expression was reduced through Sucla2 knockdown in 
GC2 cells; also, Sucla2 was decreased by increasing 
the Sucla2-targeting siRNA reagent from 6 μL in the 
Si1 group to 12 μL in the Si2 group (Figure 2A). 
In the GC2 cells transfected by Sucla2-targeting 
siRNA, cell viability in the Neg, Si1 group (treated 
with 6 μL Sucla2-targeting siRNA), and Si2 group 
(treated with 12 μL Sucla2-targeting siRNA) was 
100% ± 3.4%, 76.1% ± 5.3% and 59.1% ± 9.9%, 
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respectively. Compared with the control, the de-
crease in cell viability after Sucla2 knockdown was 
statistically significant in the Si1 and Si2 groups 
(Figure 2B). 
Sucla2 knockdown affects MMP of GC2 cells
In the Neg (control) group, cells grown in higher 
density emitted orange fluorescence after JC-1 
staining, indicating a higher MMP (orange arrow), 
Figure 1. Immunohistochemistry of Sucla2 in mouse testes. Sucla2 is expressed in the cytoplasm of all spermatogenic cells 
and Sertoli cells, coarse signals can be observed in pachytene spermatocyte in stages VII–XII of spermatogenesis, and 
very faint signals are observed in Leydig cells. Abbreviations: Lc — leptotene spermatocytes; Pc — pachytene spermatocytes; 
rSt — round spermatids; eSt — elongated spermatids; Ser — Sertoli cell; Ley — Leydig cell. In ×20, bars = 50 μm; 
in ×40, bars = 25 μm; in ×100, bars = 10 μm.
Figure 2. Sucla2 level and viability of GC2 cells under Sucla2 knockdown. GC2 cells were cultured in control (Neg), or 
Si1, or Si2 group transfected with different volumes of Sucla2-targeting siRNA for 6 hours as indicated in Material and 
methods, then cultured in normal medium for 24 hours. A. Sucla2 levels were determined by Western blotting; B. Viability 
of GC2 cells under Sucla2 knockdown was determined by trypan blue exclusion. Neg — control cells without siRNA, Si1 
and Si2, GC2 cells incubated with 6 or 12 μL of Sucla2 siRNA, respectively. Data represent the means ± SDs from three 
individual experiments. **Significantly different from control cells, p < 0.01.
A B
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in the Si1 and Si2 groups, cells were smaller in size 
and grew with lower density, indicating lower MMP 
(green arrow) and lower viability (Figure 3A). The 
red/green fluorescence ratio was 1.09 ± 0.07, 0.92 ± 
± 0.02, 0.87 ± 0.01 in the control (Neg), Si1 and Si2 
groups, respectively, and the differences vs. control 
were significant (Figure 3B). Thus, the knockdown of 
Sucla2 decreased MMP in the GC2 cells.
ATP production and ROS level in GC2  
cells under Sucla2 knockdown
The ATP production of GC2 cells in the Neg, Si1, and 
Si2 groups was 58.39 ± 3.76, 45.48 ± 2.28, 25.25 ± 6.11 
nmol/(L·mg) respectively (Figure 4A). Compared with 
the control (Neg) cells, Sucla2 knockdown induced 
a statistically significant decrease in ATP production 
in Si1 and Si2 cells, respectively.
The average fluorescence intensities of DCF in 
cells from the Neg, Si1, and Si2 groups were 41.72 ± 
± 1.13, 20.53 ± 0.47, 17.77 ± 0.3, respectively. 
Relative to the Neg (control cells), the increase 
in ROS production in the Si1 and Si2 groups was 
statistically significant (Figure 4B).
Effects of Sucla2 knockdown on apoptosis  
and Bcl2 level of GC2 cells 
The percentage of apoptotic GC2 cells in the Neg, 
Si1, and Si2 groups was 6.19 ± 0.68%, 6.78 ± 1.07%, 
and 9.75 ± 1.3%, respectively. Compared with the 
control, the increase of apoptotic cells in the Si2 
Figure 3. Morphology and mitochondrial membrane potential (MMP) of GC2 cells under Sucla2 knockdown. GC2 cells 
were cultured as control (Neg) or Si1 or Si2 groups transfected with 6 or 12 μL of Sucla2-targeting siRNA, respectively, 
for 6 hours as indicated in Material and methods, then cultured in normal medium for 24 hours. A. Morphology of GC2 
cells under Sucla2 knockdown. Fluorescence microscopy showed that in control cells more cells have high MMP and emit 
orange fluorescence (orange arrow) whereas in knockdown cells there are more cells with lower MMP that emit green flu-
orescence (green arrow). Bars = 50 μm; B. MMP of GC2 cells under Sucla2 knockdown was determined by flow cytome-
try as described in Material and methods. The red/green fluorescence ratio (Y/X ratio) is taken as an indicator of MMP. 
Data represent the means ± SDs from three individual experiments. **Significantly different from control cells, p < 0.01.
A
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group was significant, and the data revealed that 
the knockdown of Sucla2 induces apoptosis in GC2 
cells (Figure 5A). 
The level of anti-apoptotic factor Bcl2, as de-
termined by Western blotting, was significantly de-
creased by Sucla2 knockdown of GC2 cells (p < 0.01, 
Figure 5B). Thus, Sucla2 knockdown induced apopto-
sis of GC2 cells through the mitochondrial apoptotic 
pathway. 
Discussion
Spermatogenesis involves the self-renewal of sper-
matogonial stem cells, differentiation, meiosis of 
spermatocytes and spermiogenesis [15]. This process 
is characterized by a delicate balance between cell 
proliferation and germ cells apoptosis [16]. Mitochon-
dria are complex organelles that not only participate 
in ATP synthesis and ROS production, but also play 
important roles in proliferation, differentiation, and 
apoptosis of germ cells [17, 18]. Mitochondrial func-
tion depends not only on mitochondrial molecules en-
coded by nuclear DNA (nDNA), but also depends on 
molecules encoded by mitochondria DNA (mtDNA) 
[19, 20]. The literature shows that many kinds of 
abnormal expression of mitochondrial proteins are 
associated with mitochondrial dysfunction, resulting 
in mitochondrial diseases such as neurodegeneration, 
cancer, infertility, and ageing [21–23]. 
Recently, it has been shown that the abnormal 
forms of some proteins encoded by nDNA are related 
to the maintenance of mtDNA. For example, nuclear 
genetic mutations in EFTu (Tu translation elongation 
factor, mitochondrial) may result in a disorder of the 
Figure 4. ATP and reactive oxygen species (ROS) levels of GC2 cells under Sucla2 knockdown. GC2 cells were cultured 
in control (Neg), or Si1 group, or Si2 group transfected with different volumes of Sucla2-targeting siRNA for 6 hours 
as indicated in Methods, then cultured in normal medium for 24 hours. A. ATP production of GC2 cells under Sucla2 
knockdown; B. ROS level of GC2 cells under Sucla2 knockdown. Data represent the means ± SDs from three individual 
experiments. *, **Significantly different from control cells, p < 0.05 and p < 0.01, respectively.
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mitochondrial respiratory chain [24]; nuclear genetic 
mutation in DGUOK (mitochondrial deoxyguanosine 
kinase) [25] or POLG (mitochondrial DNA polymer-
ase gamma) [24] is associated with mtDNA depletion 
and disorder of the mitochondria.
Sucla2, encoded by a nuclear gene, is related 
to mtDNA depletion and mitochondrial dysfun c - 
tion [3, 26]. Sucla2 is the b subunit of Succinyl coen-
zyme A synthase present in the mitochondrial matrix, 
and catalyzes the reversible synthesis of ATP in tricar-
boxylic acid cycle. The defects in the SUCLA2 gene 
can result in myopathic mitochondrial DNA depletion 
syndrome, which is characterized by a significant re-
duction in mtDNA content [1]. In a culture medium 
of fibroblasts from a patient with SUCLA2 mutation, 
Western blotting showed a significant decrease in 
Sucla2 protein and mitochondrial ATP contents and 
enhanced levels of ROS [6].
Owing to the importance of Sucla2 in mitochon-
drial function, we focused on its function in the male 
reproductive system. Our previous study showed 
that Sucla2 expression decreased in rat testes with 
failure of spermatogenesis, and decreased in mouse 
spermatogonia cell line (GC1 cells) with an increase 
in apoptotic cells; moreover, Sucla2 was strongly 
expressed in spermatocytes of stages VII–XII in rat 
spermatogenesis [8]. Yet, whether the expression of 
Sucla2 in mouse testes is similar to that in rat testes 
is unknown; also, the function of Sucla2 in the sper-
matocyte is still unclear. As shown in present study, 
Figure 5. Apoptosis and Bcl2 level of GC2 cells under Sucla2 knockdown. GC2 cells were cultured in control (Neg), or 
Si1 group, or Si2 group with knockdown Sucla2 for 6 hours as indicated in Material and methods, then cultured in normal 
medium for 24 hours. A. Apoptosis of GC2 cells under Sucla2 knockdown was studied by flow cytometry. The Annexin 
V-positive/PI-negative (lower right quadrant, LR) were early apoptotic cells, the double-positive (upper right quadrant, 
UR) were late apoptotic cells, the Annexin V-negative/PI-positive (upper left quadrant, UL) were dead/necrotic cells, and 
the double-negative cells (lower left quadrant, LL) were viable cells. The sum of LR and UR is the percentage of apop-
totic GC2 cells; B. Bcl2 level of GC2 cells with Sucla2 knockdown was determined by Western blotting. Data represent 
the means ± SDs from three individual experiments. **Significantly different from control cells, p < 0.01.
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in mouse testis, Sucla2 is located specifically in the 
cytoplasm of all spermatogenic cells, with coarse 
signals in the pachytene spermatocytes (Pc) in stages 
VII–XII and very faint signal in interstitial cells, such 
as Leydig cells (Lc) (Figure 1). The expression of 
Sucla2 in mouse testis is similar to that in rat testis; 
also, Sucla2 is associated with the developmental 
stages of spermatogenesis. Based on these results, 
we suspect that Sucla2 is one of the important mark-
ers that is decreased by some stresses, and related 
to mitochondrial dysfunction and the development 
of germ cells. In present study, Sucla2 was knocked 
down by Sucla2-targeting siRNA transfection in GC2 
cells resulting in decreased cell viability. This finding 
agrees with the results of our previous study, in which 
Sucla2 expression was decreased in impaired rat 
spermatogenesis with an increased ratio of apoptotic 
germ cells [8]. 
Mitochondrial membrane potential, a sensitive 
indicator of mitochondrial function, was determined 
by flow cytometry. We found that MMP in GC2 cells 
was reduced significantly by Sucla2 knockdown; 
moreover, other indicators of mitochondrial status 
showed that Sucla2 knockdown decreased ATP 
and increased ROS contents. An increasing ratio 
of apoptotic GC2 cells was induced gradually by 
increasing the Sucla2-targeting siRNA reagent, and 
Bcl2, a marker of the mitochondrial apoptotic path-
way, was also reduced in cells after Sucla2-targeting 
siRNA transfection. These results suggest that the 
knockdown of Sucla2 decreased the viability of sper-
matocytes by inducing mitochondrial dysfunction and 
apoptosis of germ cells. Although Sucla2 has been 
referred to in studies of patients with mitochondrial 
depletion syndrome (MDS) including progressive 
external ophthalmoplegia (PEO), ataxia-neuropathy, 
and mitochondrial neurogastrointestinal encephalo-
myopathy [26, 27], yet its function in germ cells has 
rarely been investigated. The present results shed a 
light on the relationship between Sucla2 and apoptosis 
or degeneration of male germ cells and encourage 
further research in this area of study. 
Mitochondria are multitasking organelles [28], 
and many environmental and stress stimuli can cause 
mitochondrial dysfunction [29, 30], thereby affect-
ing spermatogenesis [31–34]. The present study is 
a follow-up to our previous works, which showed that 
Sucla2 expression decreased in testes and GC1 cells 
with increasing apoptotic cells after exposure to endo-
crine disruptor BDE47 [8]. Our present data indicate 
that Sucla2 most likely serves as a link between mito-
chondrial function and apoptosis of germ cells, and 
may be one of the targeting markers affected by some 
stress stimulators. Most studies on Sucla2 focused on 
the mutation in the SUCLA2 nuclear gene and its re-
lationship with the clinical syndromes of patients [1, 3, 
6, 26]. On the other hand, the majority of studies 
on the apoptosis of germ cells were focused on the 
detection of markers of mitochondrial dysfunction or 
apoptosis, such as ATP production, ROS level, Bcl2, 
or caspase 3/9 [8, 18, 35, 36]. Our studies provide a new 
way of understanding the mechanism of mitochondrial 
dysfunction and the apoptosis of germ cells affected by 
mitochondrial proteins. Based on our findings, Sucla2 
is specifically expressed in germ cells and is related 
to developmental stages of mouse spermatogene-
sis; knockdown of Sucla2 decreases the viability of 
mouse spermatocytes, probably by inducing apoptosis 
through injuring the mitochondrial function of cells.
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